# Owkin will build end-to-end AI agents designed to operate within AstraZeneca's internal infrastructure and decision-making workflows.

*genai · news · 2026-05-13 · Benzinga*

## Key points

- Owkin will build end-to-end AI agents integrated directly into AstraZeneca's internal decision-making workflows.
- The K Pro platform combines multimodal data with agentic AI to aid pharmaceutical research and strategy.
- AstraZeneca's teams will deploy these AI agents under existing enterprise security, governance, and compliance standards.
- Ongoing collaborative diagnostic work continues under Waiv, Owkin's diagnostics division spinout.

**Companies:** AstraZeneca, Owkin

[Read the full story on Benzinga](https://www.benzinga.com/news/health-care/26/05/52532890/owkin-expands-astrazeneca-collaboration-around-k-pro-ai-platform)

---

Canonical: https://newsio.io/n/fdc33995-d1c9-4c0c-b90b-c1db1402654a/owkin-will-build-end-to-end-ai-agents-designed-to-operate-within-astrazenecas-in
Summarized by Newsio from Benzinga. https://newsio.io/how-it-works